Korea Arlico Pharm Co Ltd
KOSDAQ:260660
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
K
|
Korea Arlico Pharm Co Ltd
KOSDAQ:260660
|
KR |
|
M
|
Merck KGaA
DUS:MRK
|
DE |
|
G
|
GoGold Resources Inc
F:GGD
|
CA |
|
Prodigy Gold NL
ASX:PRX
|
AU |
|
A
|
Abercrombie & Fitch Co
DUS:AFT
|
US |
|
Koryx Copper Inc
XTSX:KRY
|
CA |
|
N
|
Nissan Chemical Corp
DUS:NSC
|
JP |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Korea Arlico Pharm Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Korea Arlico Pharm
Korea Arlico Pharm Co., Ltd. engages in the provision of development and manufacture of pharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 228 full-time employees. The company went IPO on 2018-02-12. The firm manufactures and sells medicines such as hyperlipidemia, cerebrovascular disease, digestive medicine, allergies, respiratory medicine and others. In addition, the Company is also engaged in the manufacture of non-pharmaceutical products such as sun cream, hand cream and medical devices. The firm sells its products in domestic and overseas markets.
- Sede central
- Corea KR
- Empleados
- 228
- Fecha de salida a bolsa
- 12 feb., 2018
